North America
The North America Precision Oncology Market is well-established, primarily driven by advancements in cancer genomics and government-backed initiatives for personalized medicine. In the United States, substantial investments in genomics and cancer research by organizations like the National Cancer Institute (NCI) have propelled market growth. Canada is also investing in...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian